Interstitial pneumonitis secondary to leuprorelin acetate for prostate cancer.
Tan, Hsern Ern; Lake, Fiona.
Respirol Case Rep
; 4(2): e00146, 2016 04.
Artigo em Inglês | MEDLINE | ID: mdl-27081487
Leuprolide acetate-induced generalized papular eruption.
Efficacy and Tolerability of Leuprorelin Acetate (Eligard®) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3- or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer.
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Anaphylaxis to leuprolide acetate depot injection during treatment for prostate cancer.
Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study.
Hypersensitivity vasculitis associated with leuprolide (Lupron).
Granulomes induits par des injections de leuproréline acétate (Enantone ®).
Pharmacokinetic-Pharmacodynamic Model for the Testosterone-Suppressive Effect of Leuprolide in Normal and Prostate Cancer Rats.
Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis.
Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer.